Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers
Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011
Approaches for the Identification of New Biomarkers for Alzheimer's Disease
Christian Czech, CNS Researcher, F. Hoffman-La Roche, speaking at European Biomarkers Summit 2010.
Urine Molecular Profiling Distinguishes Health and Disease: A Fresh View on Diagnostics
Simone Koenig, Professor, University of Munster, speaking at European Biomarkers Summit 2010.
Looking Forward By Looking Backward: A Possible Step Toward Realization Of Personalized Medicine
Richard Ablin, University of Arizona, speaking at European Biomarkers Summit 2010.
An Approach to Analyzing Data From a Large Sub-Population of Single Cells
Richard Fekete, Senior Manager, Sample Preparation Department, Life Technologies, speaking at Single Analysis Summit 2010.
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
Personalized Stem Cell Therapies for Tissue Regeneration
Sheldon Schaffer, Vice President, Aastrom Biosciences, Speaking at Stem Cells World Congress 2010.
Double Knockdown of Transcription Factors DP1 and DP2 Revealed Their Unique Roles in the Regulation of Matrix Metalloproteinase as Well as Cell Cycle Progression
Kenichi Yoshida, Associate Professor, Meiji University, speaking at European Biomarkers Summit 2009